ABUS vs CLOV
Arbutus Biopharma Corp (ABUS) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ABUS and CLOV stock pages for the full models.
Not investment advice.